Form 8-K - Current report:
SEC Accession No. 0001641172-25-006224
Filing Date
2025-04-25
Accepted
2025-04-25 16:30:33
Documents
15
Period of Report
2025-04-24
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48011
2 ex16-1.htm EX-16.1 4935
  Complete submission text file 0001641172-25-006224.txt   276540

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cdt-20250424.xsd EX-101.SCH 3839
4 XBRL DEFINITION FILE cdt-20250424_def.xml EX-101.DEF 26712
5 XBRL LABEL FILE cdt-20250424_lab.xml EX-101.LAB 36866
6 XBRL PRESENTATION FILE cdt-20250424_pre.xml EX-101.PRE 25336
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6013
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25874600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)